相关期刊:《International Journal of Ophthalmology(English edition)》《Chinese Medical Journal》《World Journal of Pediatrics》《Open Journal of Ophthalmology》更多>>
Supported by the National Natural Science Foundation of China (No.81670885);the Science and Technology Program of Guangdong Province, China (No.2013B020400003);the Science and Technology Program of Guangzhou, China (No.15570001)
AIM: To report the effects of intravenous high-dose glucocorticoids(iv GC) and orbital decompression(OD) surgery for treatment of sight-threatening thyroid-associated ophthalmopathy(TAO).METHODS: A retrospective revie...
Supported by National Natural Science Foundation of China(No.81170874)
AIM: To evaluate the benefit and harms of high-dose intravenous glucocorticoids(IVGC) as first-line treatment for Graves’ ophthalmopathy(GO).METHODS: A systematic review and Meta-analysis of randomized clinical trial...
Supported by National Natural Science Foundation of China(No.81200719);China Postdoctoral Science Foundation(No.2013M543579; No.2014T71013);Key Specialized Projects in Nanjing(No.SZDZK2016008)
Currently, thyroid-associated ophthalmopathy (TAO) lacks effective treatment due to our lack of clarity in its immunopathogenesis. Orbital fibroblasts play a key role in altering inflammation and immune response in TA...
AIM: To evaluate retinal nerve fiber layer(RNFL)thickness profile in patients of thyroid ophthalmopathy with no clinical signs of optic nerve dysfunction.METHODS: A prospective, case-control, observational study c...